Canopy Growth teams with NHL alumni to study cannabis-based concussion treatment

cannabis
cannabis

Smiths Falls-based Canopy Growth will study the effects on cannabinoids on patients facing complications from concussions thanks to a new partnership with the NHL Alumni Association and Neeka Health Canada.

If successful, the partners hope the research could unlock new avenues to use cannabinoids in post-concussion treatment for athletes and everyday patients.

The local pot producer announced over the weekend it will work with its partners to determine how effective cannabis can be in addressing common post-concussion complications, such as depression, dementia or chronic traumatic encephalopathy (CTE).

OBJ360 (Sponsored)

The research will look to improve cognitive functions for the estimated 1.6 million to 3.8 million athletes that suffer concussions annually, 10 to 15 per cent of whom go on to develop symptoms of mental degradation. About 100 former NHL players will participate in the study.

Trials will begin this summer and are expected to last one year.

Get our email newsletters

Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.

By signing up you agree to our Terms of Use and Privacy Policy. You may unsubscribe at any time.

Sponsored

Sponsored